Editorial: awareness and prevention of intravenous iron-induced hypophosphataemia.
作者信息
Musgrove John, Wolf Myles
机构信息
Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
出版信息
Aliment Pharmacol Ther. 2019 Sep;50(5):609-610. doi: 10.1111/apt.15437.
PMID:31414533
Abstract
摘要
相似文献
1
Editorial: awareness and prevention of intravenous iron-induced hypophosphataemia.社论：静脉注射铁剂所致低磷血症的认识与预防
Aliment Pharmacol Ther. 2019 Sep;50(5):609-610. doi: 10.1111/apt.15437.
2
Editorial: awareness and prevention of intravenous iron-induced hypophosphataemia. Authors' reply.社论：静脉注射铁剂所致低磷血症的认识与预防。作者回复。
Aliment Pharmacol Ther. 2019 Sep;50(5):610-611. doi: 10.1111/apt.15443.
3
Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark.回应：丹麦炎性肠病合并缺铁性贫血患者中异麦芽糖酐铁1000与羧基麦芽糖铁的经济学评价
Adv Ther. 2019 Aug;36(8):1821-1825. doi: 10.1007/s12325-019-00993-8. Epub 2019 Jun 1.
4
Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark.信函：丹麦炎症性肠病合并缺铁性贫血患者中异麦芽糖酐铁1000与羧基麦芽糖铁的经济学评价
Adv Ther. 2019 Aug;36(8):1817-1820. doi: 10.1007/s12325-019-00990-x. Epub 2019 Jun 1.
5
Randomized trial of intravenous iron-induced hypophosphatemia.静脉铁诱导低磷血症的随机试验。
JCI Insight. 2018 Dec 6;3(23):124486. doi: 10.1172/jci.insight.124486.
6
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk.高剂量静脉铁剂的选择决定了低磷血症风险。
PLoS One. 2016 Dec 1;11(12):e0167146. doi: 10.1371/journal.pone.0167146. eCollection 2016.
7
8
An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark.丹麦炎性肠病伴缺铁性贫血患者用异麦芽糖铁 1000 与羧基麦芽糖铁进行经济学评价。
Adv Ther. 2018 Dec;35(12):2128-2137. doi: 10.1007/s12325-018-0827-5. Epub 2018 Nov 19.
9
Symptomatic hypophosphataemic osteomalacia secondary to the treatment with iron carboxymaltose detected in bone scintigraphy.骨闪烁显像检测到继发于羧基麦芽糖铁治疗的有症状性低磷性骨软化症。
Rev Esp Med Nucl Imagen Mol. 2016 Nov-Dec;35(6):391-393. doi: 10.1016/j.remn.2016.04.006. Epub 2016 May 27.
10
Intravenous iron isomaltoside (Monofer)-induced hypophosphataemia: a case report.静脉注射异麦芽糖铁（莫诺菲）引起的低磷血症：一例报告。
Hong Kong Med J. 2022 Jun;28(3):267-269. doi: 10.12809/hkmj219354.
Zotero 插件